{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0030154",
      "entity_text" : "cell differentiation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:679",
      "entity_text" : "dimethyl sulfoxide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In fact many adaptations to the standard treatment protocol have been considered to improve efficacy including skin pre-treatment with the malignant cell differentiation potentiator dimethyl sulfoxide 44, light dose fractionation 45, 46, low fluence rate light administration 47 as well as combinations with other techniques (e.g., low dose Photofrin 48, hyperthermia 49, 50, iontophoresis 51, and bioreductive drugs 52).",
  "reading_complete" : "2020-08-02T18:32:25Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:26:57Z",
  "trigger" : "potentiator",
  "evidence" : [ "cell differentiation potentiator dimethyl sulfoxide" ],
  "pmc_id" : "6032951",
  "score" : 0
}